Buck Wealth Strategies’s Royalty Pharma RPRX Stock Holding History

Buck Wealth Strategies’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$505	Buy	+9	New	+$468	﹤0.01%	1003

Other funds holding RPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking Tokyo, Japan $45.7B AUM 34.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Buck Wealth Strategies's RPRX Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Royalty Pharma (RPRX) in Q2 2026: 9 shares worth $505. The stake represents ﹤0.01% of the portfolio and ranks #1003 among its holdings.

322 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Buck Wealth Strategies held 9 shares of Royalty Pharma worth $505 as of Q2 2026.
Royalty Pharma was a new Buck Wealth Strategies position in Q2 2026.
Royalty Pharma made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #1003 holding.
322 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.